C
Chuan Shih
Researcher at National Health Research Institutes
Publications - 25
Citations - 616
Chuan Shih is an academic researcher from National Health Research Institutes. The author has contributed to research in topics: Virtual screening & Agonist. The author has an hindex of 11, co-authored 25 publications receiving 460 citations.
Papers
More filters
Journal ArticleDOI
Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1
Yi-Hui Peng,Shau-Hua Ueng,Chen-Tso Tseng,Ming-Shiu Hung,Jen-Shin Song,Jian-Sung Wu,Fang-Yu Liao,Yu-Shiou Fan,Mine-Hsine Wu,Wen-Chi Hsiao,Ching-Cheng Hsueh,Shu Yu Lin,Chia-Yi Cheng,Chih-Hsiang Tu,Lung-Chun Lee,Ming-Fu Cheng,Kak-Shan Shia,Chuan Shih,Su-Ying Wu +18 more
TL;DR: This study presents the structure of IDO1 in complex with 24, a NLG919 analogue with potent activity and demonstrates that extensive hydrophobic interactions and the unique hydrogen bonding network contribute to the great potency of imidazoleisoindole derivatives.
Journal ArticleDOI
Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification
Yi Yu Ke,Vivek Singh,Mohane Selvaraj Coumar,Yung Chang Hsu,Wen Chieh Wang,Jen Shin Song,Chun Hwa Chen,Wen-Hsing Lin,Szu Huei Wu,John T.A. Hsu,Chuan Shih,Hsing Pang Hsieh +11 more
TL;DR: Molecular dynamics simulation and density functional theory calculation suggest that BPR056 interacted with FLT3 in a stable manner and could be chemically optimized to realize a drug-like lead in the future.
Journal ArticleDOI
Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy.
Shu Yu Lin,Teng Kuang Yeh,Ching Chuan Kuo,Jen Shin Song,Ming Fu Cheng,Fang Yu Liao,Min Wu Chao,Han Li Huang,Yi Lin Chen,Chun Yu Yang,Mine Hsine Wu,Chia-Ling Hsieh,Wen-Chi Hsiao,Yi Hui Peng,Jian Sung Wu,Li Mei Lin,Manwu Sun,Yu-Sheng Chao,Chuan Shih,Su Ying Wu,Shiow Lin Pan,Ming Shiu Hung,Shau-Hua Ueng +22 more
TL;DR: N'-(4-bromophenyl)-2-oxo-2,3-dihydro-1H-indole-5-sulfonyl hydrazide 40, which demonstrated 59% oral bioavailability and 73% of tumor growth delay without apparent body weight loss in the murine CT26 syngeneic model, is proposed as a potential drug lead worthy of advanced preclinical evaluation.
Journal ArticleDOI
Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening
Jian-Sung Wu,Shu Yu Lin,Fang-Yu Liao,Wen-Chi Hsiao,Lung-Chun Lee,Yi-Hui Peng,Chia-Ling Hsieh,Mine-Hsine Wu,Jen-Shin Song,Andrew Yueh,Chun-Hwa Chen,Shiu Hwa Yeh,Chia-Yeh Liu,Shu-Yi Lin,Teng-Kuang Yeh,John T.A. Hsu,Chuan Shih,Shau-Hua Ueng,Ming-Shiu Hung,Su-Ying Wu +19 more
TL;DR: A structure-based virtual screening strategy, comprising homology modeling, ligand-support binding site optimization, virtual screening, and structure clustering analysis, was developed and used to identify novel tryptophan 2,3-dioxygenase (TDO) inhibitors.
Journal ArticleDOI
Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity.
Cheng-Wei Yang,Yue-Zhi Lee,Hsing-Yu Hsu,Chuan Shih,Yu-Sheng Chao,Hwan-You Chang,Shiow-Ju Lee +6 more
TL;DR: The combination treatment, wherein a tylophorine compound targets TGEV and aJAK2 inhibitor blocks the alternative dominant NF-κB activation mediated by JAK2, is more effective and comprehensive than either one alone and constitutes a feasible approach for the treatment of SARS- coV or MERS-CoV.